Karin Jirström
- Therapeutic pathology
- Department Office of Clinical Sciences, Lund
- Tumor microenvironment
- Department of Clinical Sciences, Lund
- Personalized Pathology & Cancer Therapy
- Section V
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- LUCC: Lund University Cancer Centre
- Faculty of Medicine
1 – 15 of 344
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition
(
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome
(
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation
(
- Contribution to journal › Article
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
- 2023
-
Mark
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
(
- Contribution to journal › Article
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Imaging ovarian cancer - from baseline characteristics to high-risk image factors
(
- Contribution to journal › Article
-
Mark
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
(
- Contribution to journal › Article
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
-
Mark
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer : the CHAMP study
(
- Contribution to journal › Article